<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":11860,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
Bass v. Stryker Corp., 669 F.3d 501 (5th Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/2d1c5bdac65af3818981b8f10bc7a699'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/2d1c5bdac65af3818981b8f10bc7a699'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation positive" title="Positive"></div>
<div class='title left' title='Bass v. Stryker Corp., 669 F.3d 501 (5th Cir. 2012), Court Opinion'>
Bass v. Stryker Corp., 669 F.3d 501 (5th Cir. 2012), Court Opinion
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>Bass v. Stryker Corp., 669 F.3d 501 (5th Cir. 2012), Court Opinion</div>
<div class='docId'>X1H43V2003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>Bass v. Stryker Corp.</div>
<div class='displayCitation'>2012 BL 22371</div>
<div class='displayCitation'>2012 BL 31814</div>
<div class='displayCitation'>669 F.3d 501</div>
<div class='displayCitation'>bna a0d0q0h9j7</div>
<div class='displayCitation'>wkf5case:25732921</div>
<div class='displayCitation'>wkf5case:25757681</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1H43V2003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="Bass v. Stryker Corp., 669 F.3d 501 (5th Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="Bass v. Stryker Corp." />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1H43V2003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1H43V2003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1H43V2003" /><input id="title" name="title" type="hidden" value="Bass v. Stryker Corp., 669 F.3d 501 (5th Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="POSITIVE" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="2d1c5bdac65af3818981b8f10bc7a699" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1H43V2003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="false" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2F%32d%31c%35bdac%36%35af%33%38%31%38%39%38%31b%38f%31%30bc%37a%36%39%39%2Fdocument%2FX%31H%34%33V%32%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/bcite/X1H43V2003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/bcite/X1H43V2003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/bcite/X1H43V2003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/related_content/X1H43V2003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1688055382019";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">669 F.3d 501</div>
<div class="cite" data-cite-type="DocketNumber">11-10076</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 31814</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0"><tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">BL</td>
</tr></table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Fifth Circuit
</center></p>
<hr align="center" width="65%">
<p><center>
ALTON BASS, Plaintiff-Appellant v. STRYKER CORPORATION; STRYKER SALES
CORPORATION; HOWMEDICA OSTEONICS CORPORATION, doing business as Stryker
Orthopaedics, Defendants-Appellees.
</center></p>
<hr align="center" width="65%">
<p><center>
No. 11-10076
</center></p>
<p><center>
Filed January 31, 2012 Revised February 7, 2012
</center></p>
<div id="para2" printdualcolumn="true"><p>
Appeal from the United States District Court for the Northern District of
Texas.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Before JONES, Chief Judge, HAYNES, Circuit Judge, and CRONE, District
Judge.<a HREF="#fn*00" name="fnref_fn*00">[fn*]</a>
</p></div>
<div id="para2" printdualcolumn="true"><p>
<span class="fr"><a HREF="#fnref_fn*00" name="fn*00">[fn*]</a></span> United States District Judge for the Eastern District of Texas,
sitting by designation.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
HAYNES, Circuit Judge:
</p></div>
<div id="contentOpinion" printdualcolumn="true">
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Plaintiff Alton Bass ("Bass") appeals from the district court's dismissal
of his state-law tort claims against Stryker Corporation, Stryker Sales
Corporation, and Howmedica Osteonics Corporation, doing business as Stryker
Orthopaedics (collectively, "Stryker") pursuant to Federal Rule of Civil
Procedure <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X144L16003?jcsearch=Federal%20Rule%20of%20Civil%20Procedure%2012(b)(6)&amp;summary=yes#jcite">12</a>(b)(6). In his complaint, Bass alleged that a hip replacement
product manufactured by

Stryker malfunctioned and caused him injury. Bass argues that the district
court erred in concluding that <i>Riegel v. Medtronic, Inc.</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20us%20312&amp;summary=yes#jcite">552 U.S. 312</a>
(2008), forecloses his state-law claims because: (1) the Trident PSL
Acetabular Shell (or "Shell") manufactured by Stryker was not subject to
pre-market approval ("PMA") testing and therefore <i>Riegel</i> is inapplicable;
and (2) even if <i>Riegel</i> is applicable, his state-law claims merely "parallel"
the federal requirements and therefore are expressly allowed under <i>Riegel</i>.
Bass also challenges the district court's holding that his claims, even if
parallel, are impliedly preempted by <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5N0003?jcsearch=21%20U.S.C.%20%20337(a)&amp;summary=yes#jcite">21 U.S.C. &sect; 337</a>(a). For the reasons
that follow, we AFFIRM the dismissal of Bass's strict liability, design
defect, negligence, and Texas Deceptive Trade Practices Act ("DTPA") claims
to the extent they are premised on a failure to warn or a marketing defect;
AFFIRM as to Bass's breach of express warranty claims; and REVERSE and
REMAND the following: (1) Bass's strict liability and negligence claims, to
the extent they are based on manufacturing defects that violate the Food and
Drug Administration's ("FDA") Current Good Manufacturing Practices ("CGMPs")
or are inconsistent with Stryker's manufacturing processes or procedures
that were approved by the FDA; (2) his claim for breach of an implied
warranty to the extent it relies on the failure to comply with the FDA's
requirements; and (3) his DTPA claim, to the extent that it relies on a
breach of an implied warranty.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>I. FACTS AND PROCEDURAL HISTORY</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Alton Bass underwent left hip replacement surgery in August 2007. As a
part of the surgery, the surgeon implanted a hip replacement consisting of
four components, each manufactured by Stryker: (1) a Shell; (2) an Accolade
TMZ Plus Hip Stem #4.5; (3) a V40 Alumina Femoral Head; and (4) a Trident 0
Alumina Insert. Following the hip replacement, Bass allegedly began to
experience pain in his left hip, despite following all of his surgeon's
instructions after surgery. For the next two years, Bass complained to his
surgeon about

increasing pain in his left hip. Bass then underwent a revision of his hip
replacement. The surgeon determined that the Shell was too loose and revised
it. Bass alleges that the looseness <span CLASS="page_no" data-cite="2012 bl 31814 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[*2]</span> was caused by manufacturing residuals on
the Shell which prevented bony ingrowth to the Shell.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On October 23, 2009, Bass filed suit against Stryker in the Northern
District of Texas, asserting diversity jurisdiction. Bass raised a number of
state-law claims, including strict liability, negligence, breach of
warranty, and violation of the DTPA. Stryker filed a motion to dismiss,
claiming that Bass's state-law claims were preempted by the Medical Device
Amendments of 1976 ("MDA") to the Food, Drug, and Cosmetics Act ("FDCA"),
<i>see</i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5PI003?jcsearch=21%20usc%20360c&amp;summary=yes#jcite">21 U.S.C. &sect; 360c</a><i>et seq.</i>, and by <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5N0003?jcsearch=21%20U.S.C.%20%20337(a)&amp;summary=yes#jcite">21 U.S.C. &sect; 337</a>(a). The district court
granted Stryker's motion to dismiss on preemption grounds. Bass filed a
timely notice of appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>II. STANDARD OF REVIEW</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This court reviews the district court's grant of a motion to dismiss de
novo. <i>Wampler v. Sw. Bell Tel. Co.</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1CIJGK003?jcsearch=597%20f%203d%20741&amp;summary=yes#jcite">597 F.3d 741</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1CIJGK003?jcsearch=597%20f%203d%20741&amp;summary=yes#jcite">744</a> (5th Cir. 2010). All
well-pleaded facts in the complaint are accepted as true and viewed in the
light most favorable to the nonmovant. <i>Jebaco Inc. v. Harrah's Operating</i>
<i>Co.</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1C22VS003?jcsearch=587%20f%203d%20314&amp;summary=yes#jcite">587 F.3d 314</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1C22VS003?jcsearch=587%20f%203d%20314&amp;summary=yes#jcite">318</a> (5th Cir. 2009). Dismissal is appropriate when the
plaintiff has not alleged enough facts to state a claim to relief that is
plausible on its face or has failed to raise his right to relief above the
speculative level. <i>Wampler</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1CIJGK003?jcsearch=597%20f%203d%20741&amp;summary=yes#jcite">597 F.3d at 744</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>III. DISCUSSION</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A. <u>Whether the district court erred in finding that the Shell was subject</u>
<u>to PMA testing.</u>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Before addressing Bass's first argument, we provide a brief overview of
the statutory scheme applicable to medical devices. In response to the
concern that state-law governance of medical devices was inadequate,
Congress passed the MDA, giving the FDA authority to regulate medical
devices and expressly preempting certain state regulations. <i>See Riegel</i>,
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20us%20312&amp;summary=yes#jcite">552 U.S. at 315-16</a>; <i>see also</i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5Q2003?jcsearch=21%20usc%20360k&amp;summary=yes#jcite">21 U.S.C. &sect; 360k</a>.

</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The devices at issue in this litigation are Class III devices, which
receive the most federal oversight. <i>Riegel</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20us%20312&amp;summary=yes#jcite">552 U.S. at 317</a>; <i>see also Funk</i>
<i>v. Stryker Corp.</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ETR4E003?jcsearch=631%20f%203d%20777&amp;summary=yes#jcite">631 F.3d 777</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ETR4E003?jcsearch=631%20f%203d%20777&amp;summary=yes#jcite">779</a> (5th Cir. 2011) ("Trident is a Class III
device under the [FDCA]."). Most Class III devices are approved by a review
determining that the device is "substantially equivalent" to another device
exempt from the PMA process. <i>See Riegel</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20us%20312&amp;summary=yes#jcite">552 U.S. at 317</a>. This is referred
to as a <cite>&sect; 510(k)</cite> approval. <i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20U.S.%20312&amp;summary=yes#jcite">Id</a>.</i> The remaining devices are approved through
the "rigorous" PMA process. <i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20U.S.%20312&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A state-law tort claim to recover for injuries allegedly caused by a
medical device is preempted if: (1) "the Federal Government has established
requirements applicable to [the device]"; and (2) the claims are based on
state-law requirements that are "'different from, or in addition to' the
federal ones, and that relate to safety and effectiveness." <i></i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20U.S.%20312&amp;summary=yes#jcite">Id. at 321-22</a>
(quoting <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5Q2003?jcsearch=21%20U.S.C.%20%20360k(a)(1)&amp;summary=yes#jcite">21 U.S.C. &sect; 360k</a>(a)(1)). Devices that are approved through PMA
procedures automatically satisfy the "federal requirements" prong. <i></i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20U.S.%20312&amp;summary=yes#jcite">Id. at
322</a> ("Premarket approval . . . imposes `requirements' under the MDA as we
interpreted it in [<i>Medtronic, Inc. v. Lohr</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X5CCS2?jcsearch=518%20us%20470&amp;summary=yes#jcite">518 U.S. 470</a> (1996)]."). In
contrast, the <cite>&sect; 510(k)</cite> approval process does not impose federal requirements
on a device. <i>See Lohr</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X5CCS2?jcsearch=518%20us%20470&amp;summary=yes#jcite">518 U.S. at 493-94</a> ("[E]ven though the FDA may well
examine <cite>&sect; 510(k)</cite> applications for Class III devices . . . with a concern for
the safety and effectiveness of the device, . . . it did not `require'
Medtronics' pacemaker to take any particular form for any particular
reason." (internal citation omitted)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Bass argues that the district court wrongfully <span CLASS="page_no" data-cite="2012 bl 31814 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[*3]</span> concluded that the Shell,
which malfunctioned, was subject to PMA testing. He argues that: (1) the
district court was required to credit his allegation that the FDA had not
granted PMA approval to the Shell as true; and (2) even if the district
court was not required to accept the truth of his pleading, the district
court nonetheless erred

in determining that the FDA documents indicate that the FDA considered the
Shell to be a part of the Trident hip replacement system. We address both
arguments in turn.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>1. Whether the district court erred by failing to accept Bass's allegation</i>
<i>that the Shell was not subject to PMA testing.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court's decision that the Shell was subject to PMA testing
was based upon publicly available documents from the FDA. Although a
district court ruling on a motion to dismiss is required to accept all
well-pleaded facts as true, "courts `are not bound to accept as true a legal
conclusion couched as a factual allegation.'" <i>See Bell Atl. Corp. v.</i>
<i>Twombly</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X17292G003?jcsearch=550%20us%20544&amp;summary=yes#jcite">550 U.S. 544</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X17292G003?jcsearch=550%20us%20544&amp;summary=yes#jcite">555</a> (2007) (quoting <i>Papasan v. Allain</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X5CBBC?jcsearch=478%20us%20265&amp;summary=yes#jcite">478 U.S. 265</a>,
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X5CBBC?jcsearch=478%20us%20265&amp;summary=yes#jcite">286</a> (1986)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We conclude that the determination of whether the Shell was subject to the
PMA process is a question of law. We have held that where underlying facts
are not disputed, the significance of those facts becomes a question of law.
<i>See, e.g.</i>, <i>House v. Am. United Life Ins. Co.</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X17MT14003?jcsearch=499%20f%203d%20443&amp;summary=yes#jcite">499 F.3d 443</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X17MT14003?jcsearch=499%20f%203d%20443&amp;summary=yes#jcite">448</a> (5th Cir.
2007) ("We have frequently stated that the existence of an ERISA plan within
the statutory definition is a question of fact. . . . However, where the
factual circumstances are established as a matter of law or undisputed, we
have treated the question as one of law to be reviewed <i>de novo</i>."); <i>AT&amp;T</i>
<i>Corp. v. PUC</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XATN26?jcsearch=373%20f%203d%20641&amp;summary=yes#jcite">373 F.3d 641</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XATN26?jcsearch=373%20f%203d%20641&amp;summary=yes#jcite">645</a> (5th Cir. 2004) ("The material facts in this
case are not in dispute, therefore we review <i>de novo</i> the district court's
preemption decision and the interpretation of the TA96."). Bass does not
dispute that testing was done or that the documents describing the FDA's
approval process are subject to judicial notice; rather, Bass's allegation
asks the court to make a conclusion as to the legal significance of these
tests and the FDA's subsequent approval of the Trident system. Therefore, we
treat Bass's allegations that the Shell did not receive PMA testing as a
legal conclusion that the district court was not required to accept as true.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>2. Whether the district court erred in concluding that the FDA documents</i>
<i>showed that the Shell was approved through the PMA process.</i>

</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Bass alleges that the district court erroneously concluded that the Shell
was subject to PMA testing. Bass points to statements made at the FDA public
hearingin which aStrykeremployee indicated that "only the ceramic inserts
are under investigation in these systems." <i>See</i> Medical Devices Advisory
Committee, Summary Minutes of the Orthopedic and Rehabilitation Devices
Panel, at 12 (July 20, 2000), <i>available</i>
<i>at</i><u>http://www.fda.gov/ohrms/dockets/ac/00/minu</u> tes/3633m1.pdf. However, as
Stryker points out, at the same meeting, the FDA Director of General and
Restorative Devices "clarified for the panel that they would be voting on an
entire system and not just the ceramic on ceramic interface." <i></i><cite>Id. at
16</cite>.<a HREF="#fn100" name="fnref_fn100">[fn1]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Additionally, there are numerous <span CLASS="page_no" data-cite="2012 bl 31814 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[*4]</span> indications that theFDA considered the
Shell to be a part of the Trident system. Perhaps most significantly, the
PMA supplements included in the record indicate that changes to the labeling
and design of the Shell were approved through the PMA process. Supplemental
approval ofchanges is required for any device which has received PMA
approval. <i>See Lewkut</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XIAMVON?jcsearch=724%20f%20supp%202d%20648&amp;summary=yes#jcite">724 F. Supp. 2d at 655</a> ("[S]everal supplements
approved by the FDA through the PMA process after the Trident System's
initial approval refer to the acetabular shell component in a mannerthat
strongly suggests that it had already been approved."); <i>Purcel v. Advanced</i>
<i>Bionics Corp.</i>, No. <cite>3:07-cv-1777</cite>, [<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1Q6LCBBMLO2?jcsearch=2010%20BL%20149061&amp;summary=yes#jcite">2010 BL 149061</a>], 2010 U.S. Dist. LEXIS 67109, at *8-9 (N.D.
Tex. June 30, 2010) ("Supplemental

premarket approval is evaluated largely by the same procedures, criteria,
and extensive scrutiny as the original PMA process."). Furthermore, the
record also indicates that the safety and effectiveness data for the PMA
testing refers to the Shell as a component of the system. For these reasons,
we hold that the district court did not err in determining that the Shell in
its entirety was subject to PMA approval and therefore satisfied the
"federal requirement" prong of <i>Riegel</i>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  B. <u>Whether the district court erred in determining that Bass's complaint</u>
<u>failed to plead parallel claims.</u>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We now turn to the preemption question. Although "common-law causes of
action for negligence and strict liability do impose `requirement[s],'"
<i>Riegel</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20us%20312&amp;summary=yes#jcite">552 U.S. at 323-24</a>; <i>see also </i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20U.S.%20312&amp;summary=yes#jcite">id. at 324</a> ("Absent other indication,
reference to a State's `requirements' includes its common-law duties."),
that is not the end of our inquiry. "[Section] 360k does not prevent a State
from providing a damages remedy for claims premised on a violation of FDA
regulations; the state duties in such a case `parallel,' rather than add to,
federal requirements." <i></i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20U.S.%20312&amp;summary=yes#jcite">Id. at 330</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court determined that Bass's claims do not parallel FDA
requirements.<a HREF="#fn200" name="fnref_fn200">[fn2]</a> Two subsequent opinions from our court-<i>Funk</i>,
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ETR4E003?jcsearch=631%20f%203d%20777&amp;summary=yes#jcite">631 F.3d 777</a>, and <i>Hughes v. Boston Scientific Corp.</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ESLIK003?jcsearch=631%20f%203d%20762&amp;summary=yes#jcite">631 F.3d 762</a> (5th Cir.
2011)-compel an opposite conclusion as to some of his claims.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Funk</i>, we dealt with a nearly identical claim that the Shell failed to
attach correctly due to impurities in the manufacturing process.
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ETR4E003?jcsearch=631%20f%203d%20777&amp;summary=yes#jcite">631 F.3d at 782</a>. In that case, we recognized that such an injury could lead
to a parallel claim but held that the plaintiff's pleadings were too
conclusory to state a claim. <i>See <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ETR4E003?jcsearch=631%20F.3d%20777&amp;summary=yes#jcite">id</a>.</i> ("[Funk's] claim that Stryker violated
FDA manufacturing requirements

when producing Trident was not legally cognizable as set out in his
pleadings before the district court. . . . This complaint is impermissibly
conclusory and vague."). Specifically, Funk's complaint did
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      not specify the manufacturing defect; nor d[<cite>id</cite>] it specify a
    causal connection between the failure of the specific manufacturing
    process and the specific defect in the process that caused the
    personal injury. Nor d[<cite>id</cite>] the complaint tell us how the
    manufacturing process failed, or how it deviated from the FDA
    approved manufacturing process.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ETR4E003?jcsearch=631%20F.3d%20777&amp;summary=yes#jcite">Id</a>.</i> This conclusion was consistent with a number of other courts holding
that to plead a parallel claim successfully, a plaintiff's allegations that
the manufacturer violated FDA regulations <span CLASS="page_no" data-cite="2012 bl 31814 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[*5]</span> must meet the <i>Twombly</i> plausibility
standard. <i>See, e.g.</i>, <i>In re Medtronic Inc.</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EBQAK003?jcsearch=623%20f%203d%201200&amp;summary=yes#jcite">623 F.3d 1200</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EBQAK003?jcsearch=623%20f%203d%201200&amp;summary=yes#jcite">1203</a> (8th Cir.
2010); <i>Horowitz v. Stryker Corp.</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1AJT90003?jcsearch=613%20f%20supp%202d%20271&amp;summary=yes#jcite">613 F. Supp. 2d 271</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1AJT90003?jcsearch=613%20f%20supp%202d%20271&amp;summary=yes#jcite">280</a> (E.D.N.Y. 2009);
<i>Parker v. Stryker Corp.</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X19RD9Q003?jcsearch=584%20f%20supp%202d%201298&amp;summary=yes#jcite">584 F. Supp. 2d 1298</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X19RD9Q003?jcsearch=584%20f%20supp%202d%201298&amp;summary=yes#jcite">1301</a> (D. Colo. 2008); <i>cf.</i>
<i>Bausch v. Stryker Corp.</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EOF96003?jcsearch=630%20f%203d%20546&amp;summary=yes#jcite">630 F.3d 546</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EOF96003?jcsearch=630%20f%203d%20546&amp;summary=yes#jcite">558</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EOF96003?jcsearch=630%20f%203d%20546&amp;summary=yes#jcite">560</a> (7th Cir. 2010)
(acknowledging that <i>Twombly</i> applies, but rejecting the notion that <i>Twombly</i>
requires the plaintiff to allege which specific regulation was violated).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Hughes</i>, we noted that any claim asserting a state-law tort action
despite compliance with FDA regulations was preempted by the MDA.
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ESLIK003?jcsearch=631%20f%203d%20762&amp;summary=yes#jcite">631 F.3d at 768</a>. However, state common law claims "are not preempted,
provided that such claims are premised entirely on violation of the
applicable federal requirements." <i></i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ESLIK003?jcsearch=631%20F.3d%20762&amp;summary=yes#jcite">Id. at 770</a>. Importantly, a formal finding
of a violation by the FDA was not required to plead a parallel action. <i>See</i>
<i></i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ESLIK003?jcsearch=631%20F.3d%20762&amp;summary=yes#jcite">id. at 772</a> ("We are persuaded that any additional `formal' findingor
enforcement action by the FDA is not an `implicit precondition' to suit
under the facts of this case."). We ultimately held that the cause of action
survived where the plaintiff provided expert testimony showing that the
medical device manufacturer had "violated the plain text of the [Medical
Device Reporting] regulations." <i></i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ESLIK003?jcsearch=631%20F.3d%20762&amp;summary=yes#jcite">Id. at 773</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Under <i>Funk</i> and <i>Hughes</i>, Bass has sufficiently pleaded parallel claims in

his first amended complaint, to the extent that the claims are based upon
manufacturing defects resulting from violations of federal regulations. Bass
alleges that his injury was caused by the Shell's failure to attach to the
bone. The complaint further alleges that the Shell was adulterated due to
violations of <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XMJ9IC003?jcsearch=21%20C.F.R.%20%20820.20(a)&amp;summary=yes#jcite">21 C.F.R. &sect;&sect; 820.20</a>(a), <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XMJ9IC003?jcsearch=21%20C.F.R.%20%20820.20(b)(2)&amp;summary=yes#jcite">820.20</a>(b)(2), and <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XMJ9J6003?jcsearch=21%20C.F.R.%20%20820.70(e)&amp;summary=yes#jcite">820.70</a>(e). In
support of the allegations that the Shell was adulterated, Bass pleaded that
Stryker initiated a recall on its Shell, and that the recall "included
Plaintiff's specific hip device." Bass also alleged that the FDA sent a
warning letter to Stryker five months before his surgery, which included a
notice that Stryker failed to verify and implement changes to reduce the
Final Rinse Tank bioburden. <i>See</i> Letter from Timothy A. Ulatowski, Director,
FDA Office of Compliance to Michael McGrath, General Manager/Vice President,
Stryker Ireland (Mar. 15, 2007),
<u>http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2007/ucm076</u>
326.htm [hereinafter Warning Letter]. According to Bass, the recall followed
an investigation in which the FDA noted that manufacturing residuals in
excess of those permitted by the FDA were found on the Shells and that the
Shells were "adulterated within the meaning of section . . .
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5OG003?jcsearch=21%20U.S.C.%20%20351(h)&amp;summary=yes#jcite">21 U.S.C. &sect; 351</a>(h)." Warning Letter at 1. Bass also pleaded that excess
bioburden (microbial contaminant) and manufacturing residuals on the Shells
are known to prevent bony ingrowth, resulting in a loose cup, which is the
injury that Bass pleads. In summary, Bass pleaded: (1) he received a Shell
implant; (2) the FDA had previously warned Stryker of bioburden in excess of
FDA regulations in its final rinse of the Shells; (3) after Bass's surgery,
Stryker ultimately voluntarily recalled those Shells, including the Shell
specifically used in Bass's implant; (4) Bass suffered from a loose Shell
due to a lack of bony ingrowth; and (5) the lack of bony ingrowth is a known
<span CLASS="page_no" data-cite="2012 bl 31814 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[*6]</span> effect of an excess of bioburden and manufacturing residuals on Shells. Bass
has thus pleaded sufficient facts to find that his injury plausibly resulted
from a violation of FDA standards in connection with his manufacturing
defect claims, as more fully explained below, and, therefore, has pleaded a
non-conclusory

parallel claim under our precedents in <i>Funk</i> and <i>Hughes</i>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Stryker argues that Bass "does not plead that his doctor saw any signs of
contamination on the device when it was removed or that the Plaintiff had an
infection at the sight of the hip replacement." Stryker argues that Bass's
claim is essentially one of <i>res ipsa loquitur</i>, which we rejected in <i>Funk</i>.
<i>See</i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ETR4E003?jcsearch=631%20f%203d%20777&amp;summary=yes#jcite">631 F.3d at 782</a>. However, Bass's pleadings are more detailed than those
in <i>Funk</i>. <i>See <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ETR4E003?jcsearch=631%20F.3d%20777&amp;summary=yes#jcite">id</a>.</i> Unlike the <i>Funk</i> complaint, Bass "specifies with
particularity what went wrong in the manufacturing process and cites the
relevant FDA manufacturing standards Stryker allegedly violated." <i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ETR4E003?jcsearch=631%20F.3d%20777&amp;summary=yes#jcite">Id</a>.</i>
Evidence that the doctor noticed contamination on the Shell would provide
evidentiary support for a finding of contamination, but Stryker does not
point to any case stating that such allegations are required at the motion
to dismiss stage. We conclude that these pleadings are sufficient as to
Bass's specific injury.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Similarly, we conclude that Bass has pleaded sufficient facts as to
Stryker's failure to conform with FDA regulations in manufacturing the
Shell. As noted above, Bass pleads that theFDA warned Strykerofexcess
contaminant in the manufacture of its Shells; that the Shells, including the
Shell implanted into Bass's hip, were ultimately recalled because of
contamination issues; and that Bass's Shell caused the type of injury that
is consistent with excess contamination. These allegations plausibly contend
that Stryker's manufacturing of the Shells failed to conform to FDA
regulations and rendered them defective.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Stryker also argues that even if Bass's allegations are not conclusory,
they nonetheless fail to allege adequately that Stryker did not comply with
FDA regulations. In support of this argument, Stryker notes that the recall
of the Shells was voluntary, that the pleadings regarding the Warning Letter
are conclusory, and that the Warning Letter "is not a final determination of
an FDA decision." Stryker also notes that at all times the Trident system
maintained its PMA approval.

</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  However, this claim is undermined by our decision in <i>Hughes</i>. The
manufacturer in <i>Hughes</i> similarly argued that "the FDA never made a `formal'
finding that [the manufacturer] failed to comply with the MDR regulations or
initiated an enforcement action against [it.]" <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ESLIK003?jcsearch=631%20f%203d%20762&amp;summary=yes#jcite">631 F.3d at 772</a>. We rejected
the argument that a formal finding of a violation or an enforcement action
was a necessary precursor of a parallel claim. <i></i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ESLIK003?jcsearch=631%20F.3d%20762&amp;summary=yes#jcite">Id. at 772-73</a>. The device in
that case similarly had PMA approval, <i></i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ESLIK003?jcsearch=631%20F.3d%20at%20772&amp;summary=yes#jcite">id. at 764</a>, and nothingin the opinion
suggests that the approval was revoked; rather, the fact that we
acknowledged that the FDA had not taken any enforcement action likely
precludes the possibility that the PMA approval had been revoked.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Additionally, <span CLASS="page_no" data-cite="2012 bl 31814 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[*7]</span> although the Warning Letter itself is somewhat unclear, it
does identify that the Trident Acetabular System was determined by the FDA
to be "adulterated within the meaningofsection501(h) ofthe [FDCA]." Warning
Letter at 1. The letter also mentions that the FDA had found "Final Rinse
Tank bioburden nonconformances" and notes that Stryker's response to some of
these "nonconformances" was inadequate. <i></i><cite>Id. at 3</cite>. Therefore, the letter
appears to provide further support for Bass's allegations. Furthermore, as
the Seventh Circuit noted, and as the redactions in the Warning Letter
illustrate, "courts must keep in mind that much of the product-specific
information about manufacturing needed to investigate [a medical device
claim] fully is kept confidential by federal law." <i>Bausch</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EOF96003?jcsearch=630%20f%203d%20546&amp;summary=yes#jcite">630 F.3d at 558</a>.
Therefore, asking the plaintiff to make more specific allegations than those
found in Bass's complaint may make pleading a parallel claim regarding
defective manufacturing nearly impossible. <i>See In re Medtronic</i>,
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EBQAK003?jcsearch=623%20f%203d%201200&amp;summary=yes#jcite">623 F.3d at 1209</a> (Melloy, J., dissenting) (stating that <i>Twombly</i> only
requires a degree of specificity that may be achieved without the use of
confidential documents). At this early stage, Bass has successfully alleged
that Stryker's manufacturing was conducted in violation of the applicable
federally mandated standards and resulted in the contamination

of some of the Shells, including the Shells at issue.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finally, Stryker argues that we should affirm the district court's opinion
because the regulations upon which Bass relies are CGMPs, which are "not
specific enough to constitute parallel claims." This contention is not that
the <i>allegations</i> are not specific enough to plead a claim, but rather that
the <i>regulations</i> are not specific enough to support a claim.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although thecircuits arenot in complete agreementas to what constitutes a
sufficient pleading with regard to a CGMP, the pleadings here would satisfy
any of the courts relied upon by Stryker. The key distinction between
complaints that are sufficient to withstand a motion to dismiss and those
that are not is not reliance on CGMPs, but rather the existence of a
manufacturing defect caused by a violation of federal regulations <i>and</i>
allegations connecting a defect in the manufacture of the specific device to
that plaintiff's specific injury. <i>See Wolicki-Gables v. Arrow Int'l, Inc.</i>,
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1F2TLK003?jcsearch=634%20f%203d%201296&amp;summary=yes#jcite">634 F.3d 1296</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1F2TLK003?jcsearch=634%20f%203d%201296&amp;summary=yes#jcite">1301-02</a> (11th Cir. 2011) (affirming summary judgment but
stating that a complaint is adequate if it "set[s] forth any specific
problem, or failure to comply with any FDA regulation that can be linked to
the injury alleged" (internal quotation marks omitted)); <i>In re Medtronic</i>,
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EBQAK003?jcsearch=623%20f%203d%201200&amp;summary=yes#jcite">623 F.3d at 1207</a> (noting that a plaintiff must plead that the manufacturer
"violated a federal requirement specific to the FDA's PMA approval of th[e]
Class III device" and concluding that classwide claims of generic
manufacturing defects do not survive a motion to dismiss); <i>Bausch</i>,
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EOF96003?jcsearch=630%20f%203d%20546&amp;summary=yes#jcite">630 F.3d at 555-56</a> (concluding that violations of CGMPs are not too general
to be applied by a jury). This is perhaps best summed up in <i>In re Medtronic</i>,
in which the Eighth Circuit noted that reliance on CGMPs may be appropriate
<span CLASS="page_no" data-cite="2012 bl 31814 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[*8]</span> where, as here, "a specific defective Class III device injured a consumer,
and the plaintiff did not have access to the specific federal requirements
in the PMA prior to commencing the lawsuit." <i>In re Medtronic</i>,
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EBQAK003?jcsearch=623%20f%203d%201200&amp;summary=yes#jcite">623 F.3d at 1206</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Here, Stryker alleges that permitting Bass to proceed would allow a jury

to set bioburden or residual standards that are not in the regulations. Bass
responds that the FDA approves the manufacturing process in the PMA
application, <i>see Riegel</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20us%20312&amp;summary=yes#jcite">552 U.S. at 317-18</a>, such that the jury could
measure Stryker's performance against this specific FDA-approved PMA
process.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Riegel</i>, the Supreme Court noted that "the FDA requires a device that
has received premarket approval to be made with almost no deviations from
the specifications in its approval application, for the reason that the FDA
has determined that the approved form provides a reasonable assurance of
safety and effectiveness." <i></i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20U.S.%20312&amp;summary=yes#jcite">Id. at 323</a>. The PMA application that is approved
by the FDA is more specific than the regulations. <i>Cf. </i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20U.S.%20312&amp;summary=yes#jcite">id. at 318</a> (noting
that PMA application "includes, among other things, full reports of all
studies and investigations of the device's safety and effectiveness that
have been published or should reasonably be known to the applicant; a `full
statement' of the device's `components, ingredients, and properties and of
the principle or principles of operation'; `a full description of the
methods used in, and the facilities and controls used for, the manufacture,
processing, and, when relevant, packing and installation of, such device';
samples or device components required by the FDA; and a specimen of the
proposed labeling" (quoting <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5PM003?jcsearch=21%20U.S.C.%20%20360e(c)(1)&amp;summary=yes#jcite">21 U.S.C. &sect; 360e</a>(c)(1)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Thus, we cannot agree that the regulations are too vague to be enforced by
a jury, because by the time the case is tried, the jury will have before it
the PMA application that was approved by the FDA. To the extent a plaintiff
can show that the FDA-approved processes and procedures were not followed,
and that the injury was caused by this deviation, the plaintiff's claim will
be parallel. However, if the plaintiff challenges the suitability of the
precise processes or procedures chosen by the maker, and approved by the
FDA, to achieve the broader regulatory goals, such a claim could not
proceed.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We therefore hold that if a plaintiff pleads that a manufacturer of a
Class III medical device failed to comply with either the specific processes
and procedures that were approved by the FDA or the CGMPs themselves <i>and</i>
that

this failure caused the injury, the plaintiff will have pleaded a parallel
claim. To illustrate, suppose a manufacturer had represented to the FDA in
its pre-approval documentation that each hip implant component would be
sterilized for ten minutes at 800 degrees. We would accept a parallel claim
that pleaded that the manufacturer instead sterilized the component at only
200 degrees for five minutes, as that would "violate" what it told the FDA.
However, if the plaintiff's claim was that proper sterilization required
twenty minutes at 1000 degrees or some other method of sterilization
altogether, this claim would not be allowed, as it <span CLASS="page_no" data-cite="2012 bl 31814 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[*9]</span> would "add to" the
regulatory requirements. Thus, we reject Stryker's argument that the
regulations are too vague to be enforced because Bass will have to prove
violations of the more specific, FDA-approved PMA process for this device.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Furthermore, we have already rejected a similar argument in <i>Hughes</i>. In
that case, the manufacturer argued that "permitting [a] jury to determine
whether [it] violated the FDA's reporting requirements would lead to the
possible imposition of different or additional state requirements."
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ESLIK003?jcsearch=631%20f%203d%20762&amp;summary=yes#jcite">631 F.3d at 772</a>. We noted that "any danger that the jury in th[at] case may
apply the plain terms of the MDR regulations in a different or more
stringent manner than the FDA intended is considerably mitigated by the
summary judgment evidence indicating that the FDA disapproved of [the
manufacturer's] reporting practices." <i></i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ESLIK003?jcsearch=631%20F.3d%20762&amp;summary=yes#jcite">Id. at 773</a>; <i>see also </i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ESLIK003?jcsearch=631%20F.3d%20762&amp;summary=yes#jcite">id. at 774</a> ("This
evidence strongly suggests that the FDA concluded that [the manufacturer's]
algorithm failed to satisfy the MDR regulations requiring reports of
`serious injuries.'").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Under these standards, Bass sufficiently alleged a concrete injury and a
connection between a defect in Stryker's manufacture of the Shells and
Bass's injury. Notably, unlike the plaintiffs in <i>In re Medtronic</i> and
<i>Wolicki-Gables</i>, Bass does not allege that his injury simply arises from
Stryker's failure to abide by the CGMPs, but rather alleges that the failure
to abide by its own manufacturing standards required to satisfy the CGMPs
and the PMA approval

process resulted in an unacceptable level of bioburden onhis Shell. <i>See</i>
Warning Letter at 3 (noting Final Rinse Tank nonconformances). Furthermore,
the FDA itself determined that Stryker was in violation of the CGMPs. <i>See</i>
Warning Letter at 1 ("[The FDA's] inspection revealed that . . . the methods
used in, or the facilities or controls used for, [the] manufacture, packing,
storage, or installation [of the Shells] are not in conformity with the
[CGMP] requirements of the Quality System (QS) regulation found at
[<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XSQIK0003?jcsearch=21%20C.F.R.%20820&amp;summary=yes#jcite">21 C.F.R. 820</a>]."). The fact that the FDA was able to determine, even
preliminarily, that Stryker violated the manufacturing (or sterilization)
procedures that it adopted to fulfill the CGMPs suggests that the federal
regulations are not so vague that they "[do] not spell out standards that
the court could enforce." Therefore, we hold that Bass's reliance, in part,
on CGMPs does not preclude him from having effectively alleged a parallel
claim.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  C. <u>Whether the district court erred in holding that Bass's claims are</u>
<u>preempted under <cite>&sect; 337(a)</cite>.</u>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court held that even if Bass's claims are not preempted by <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5Q2003?jcsearch=21%20U.S.C.%20%20360k&amp;summary=yes#jcite">&sect;
360k</a>, they are preempted by <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5N0003?jcsearch=21%20U.S.C.%20%20337(a)&amp;summary=yes#jcite">21 U.S.C. &sect; 337</a>(a), which provides that "all
such proceedings for the enforcement, or to restrain violations, of this Act
. . . shall be by and in the name of the United States."
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5N0003?jcsearch=21%20U.S.C.%20%20337(a)&amp;summary=yes#jcite">21 U.S.C. &sect; 337</a>(a).
The district court then held that under the workings of <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5Q2003?jcsearch=21%20U.S.C.%20%20360k&amp;summary=yes#jcite">&sect; 360k</a> and <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5N0003?jcsearch=21%20U.S.C.%20%20%20337(a)&amp;summary=yes#jcite">&sect; 337(a)</a>,
a state-law claim for injuries sustained from a PMA-tested medical device
will only be valid in the face of a statute creating causes of action for
violations of the FDCA.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We considered and rejected this interpretation of <i>Buckman Co. v.</i>
<i>Plaintiffs' Legal Committee</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X4U3HP?jcsearch=531%20us%20341&amp;summary=yes#jcite">531 U.S. 341</a> (2001), in <i>Hughes</i>. There, <span CLASS="page_no" data-cite="2012 bl 31814 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[*10]</span> we noted
that there is adifference between the "freestanding federal cause of action
based on violation of the FDA's regulations" presented by the plaintiffs in
<i>Buckman</i> and a state-law tort claim. <i>See</i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ESLIK003?jcsearch=631%20f%203d%20762&amp;summary=yes#jcite">631 F.3d at 775</a>; <i>see also Bausch</i>,
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EOF96003?jcsearch=630%20f%203d%20546&amp;summary=yes#jcite">630 F.3d at 558</a> (distinguishing between a "breach of a recognized state-law
duty" and "an implied right of action under federal law"). "<i>Riegel</i>, decided
long after <i>Buckman</i> . . . unequivocally held that parallel state claims
survive a defendant's

preemption defense under the MDA. . . ." <i>Hughes</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ESLIK003?jcsearch=631%20f%203d%20762&amp;summary=yes#jcite">631 F.3d at 775</a>. This case
is premised on state-law tort claims rather than any duties independently
created by FDA regulations.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Stryker argues that <i>Hughes</i> is distinguishable because it is based on
Mississippi law, which could allow a plaintiff to show that a defendant
violated its duty of care by proving a federal regulatory violation. Stryker
asserts that under Texas law, "statutory and regulatory violations do not
establish a violation of the state standard of care unless negligence per se
applies." It contends that even if Bass pleaded negligence per se, Texas
would not permit a showing of negligence per se based on FDCA violations.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We reject Stryker's attempt to distinguish <i>Hughes</i> on this basis; even if
Stryker is correct that Bass may not rely on the theory of negligence per
se, he may still have a negligence cause of action. Indeed, as noted by the
Texas Supreme Court, "[n]egligence per se is a tort concept whereby a
legislatively imposed standard of conduct is adopted by the civil courts as
defining the conduct of a reasonably prudent person." <i>Carter v. William</i>
<i>Sommerville &amp; Son, Inc.</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X37628?jcsearch=584%20south%20western%202d%20274&amp;summary=yes#jcite">584 S.W.2d 274</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X37628?jcsearch=584%20south%20western%202d%20274&amp;summary=yes#jcite">278</a> (Tex. 1979). "In such a case
the jury is not asked to judge whether or not the defendant acted as a
reasonably prudent person would have acted under the same or similar
circumstances; the statute itself states what a reasonably prudent person
would have done." <i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X37628?jcsearch=584%20S.W.2d%20274&amp;summary=yes#jcite">Id</a>.</i> Even though Bass may not be able to rely on the theory
of negligence per se to establish a violation of the standard of care, Bass
has sufficiently alleged facts, which, if true, would support a claim that
Stryker was negligent.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Indeed, it is evident from the Texas Supreme Court's discussion in <i>Worthy</i>
<i>v. Collagen Corp.</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XAJI00?jcsearch=967%20south%20western%202d%20360&amp;summary=yes#jcite">967 S.W.2d 360</a> (Tex. 1998), that it would not disallow
tort claims predicated on violations of FDA regulations. <i></i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XAJI00?jcsearch=967%20S.W.2d%20360&amp;summary=yes#jcite">Id. at 372-77</a>.
<i>Purcel</i> also indicated that <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5N0003?jcsearch=21%20U.S.C.%20%20337(a)&amp;summary=yes#jcite">21 U.S.C. &sect; 337</a>(a)
did not preempt negligence and products liability causes of action under
Texas law. <i>See</i>[<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1Q6LCBBMLO2?jcsearch=2010%20BL%20149061&amp;summary=yes#jcite">2010 BL 149061</a>], 2010 U.S. Dist. LEXIS 67109,
at *20-21. Yet another court concluded that "claims based on a
manufacturer's

failure to follow the FDA's regulations and procedures in manufacturing and
marketing a device are not preempted." <i>Baker v. St. Jude Med., S.C., Inc.</i>,
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X12GHEE003?jcsearch=178%20south%20western%203d%20127&amp;summary=yes#jcite">178 S.W.3d 127</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X12GHEE003?jcsearch=178%20south%20western%203d%20127&amp;summary=yes#jcite">138</a> (Tex. App.-Houston [1st Dist.] 2005, pet. denied). We
therefore conclude that Bass's parallel state claims are not preempted by
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5N0003?jcsearch=21%20U.S.C.%20%20337(a)&amp;summary=yes#jcite">21 U.S.C. &sect; 337</a>(a).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  D. <u>Which claims survive?</u>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Based ontheabove analysis, we conclude that the only claims that survive
preemption are manufacturing defect claims premised on Stryker's alleged
violations of the FDA regulations and requirements.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>1. Strict Liability</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  To plead a cause of action for strict liability under Texas law, Bass must
plead that: (1) Stryker placed the Shells in the stream of commerce; (<span CLASS="page_no" data-cite="2012 bl 31814 p 11" data-cite-type="Bloomberg" data-cite-pageno="11" data-primary-citation="">[*11]</span> 2) the
Shells were in a defective or unreasonably dangerous condition; (3) there
was a causal connection between the defect and his injury; and (4) the Shell
was expected to and did reach him without substantial change in the
condition in which it is sold. <i>See Hous. Lighting &amp; Power Co. v. Reynolds</i>,
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X2UF0Q?jcsearch=765%20south%20western%202d%20784&amp;summary=yes#jcite">765 S.W.2d 784</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X2UF0Q?jcsearch=765%20south%20western%202d%20784&amp;summary=yes#jcite">785</a> (Tex. 1988). Bass pleads two kinds of claims for strict
liability: a manufacturing defect and a "marketing defect." Bass's
manufacturing defect claims may proceed, because,as discussed above, to the
extent they arepremised on violations of FDA regulations, they are parallel
claims that are not preempted. <i>See Purcel</i>, [<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1Q6LCBBMLO2?jcsearch=2010%20BL%20149061&amp;summary=yes#jcite">2010 BL 149061</a>], 2010 U.S. Dist. LEXIS 67109, at
*34. However, to the extent that Bass's claims are premised on a "marketing
defect," Bass has not pleaded specific facts as to how the marketing of the
Trident system violated FDA regulations; therefore, we affirm the district
court's dismissal of those claims. <i>See In re Medtronic</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EBQAK003?jcsearch=623%20f%203d%201200&amp;summary=yes#jcite">623 F.3d at 1205</a>
("The FDA's PMA approval includes specific language for Class III device
labels and warnings. Plaintiffs did not allege that Medtronic modified or
failed to include FDA-approved warnings."); <i>Purcel</i>,
[<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1Q6LCBBMLO2?jcsearch=2010%20BL%20149061&amp;summary=yes#jcite">2010 BL 149061</a>], 2010 U.S. Dist. LEXIS 67109, at *20 ("Plaintiffs cite no federal requirement
obligating [the manufacturer] to warn them that the devices

were adulterated. These claims of . . . failure to warn impose a requirement
in addition to those approved by the FDA-the duty to warn consumers if
devices are adulterated-and are therefore preempted by <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5Q2003?jcsearch=21%20U.S.C.%20%20%20360k(a)&amp;summary=yes#jcite">&sect; 360k(a)</a>.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>2. Negligence</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For the same reasons that the strict liability "marketing defect" claim is
dismissed, we affirm the district court's dismissal of Bass's claims for
negligence to the extent that they are premised on a failure to warn or
improper marketing. Bass did not plead that Stryker failed to include
FDA-approved warnings, and any claim that Stryker had a duty to warn
consumers that the Shell was adulterated is preempted by <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5Q2003?jcsearch=21%20U.S.C.%20%20%20360k(a)&amp;summary=yes#jcite">&sect; 360k(a)</a>. <i>Purcel</i>,
[<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1Q6LCBBMLO2?jcsearch=2010%20BL%20149061&amp;summary=yes#jcite">2010 BL 149061</a>], 2010 U.S. Dist. LEXIS 67109, at *20.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  However, as discussed in detail above, Bass's negligent manufacturing
claims survive, as they are parallel claims that do not impose different or
additional requirements than the FDA regulations because Bass pleaded that
Stryker failed to abide by the FDA regulations in the manufacture of the
Shell. <i>Hughes</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1ESLIK003?jcsearch=631%20f%203d%20762&amp;summary=yes#jcite">631 F.3d at 775-76</a>; <i>Purcel</i>, [<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1Q6LCBBMLO2?jcsearch=2010%20BL%20149061&amp;summary=yes#jcite">2010 BL 149061</a>], 2010 U.S. Dist. LEXIS 67109, at
*12. Even if Bass cannot rely on the theory of negligence per se to prove
his case, Texas law does allow "parallel" negligent manufacturing claims to
proceed. <i>E.g.</i>, <i>Schronk v. City of Burleson</i>, No. <cite>10-07-00399-CV</cite>,
[<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1BBQVG003?jcsearch=2009%20BL%20157643&amp;summary=yes#jcite">2009 BL 157643</a>], 2009 Tex. App. LEXIS 5654, at *68 (Tex. App.-Waco July 22, 2009, pet. filed)
(allowing a claim that a medical device was "defectively manufactured,
designed, supplied, sold, or marketed to the City" to go forward); <i>Purcel</i>,
[<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1Q6LCBBMLO2?jcsearch=2010%20BL%20149061&amp;summary=yes#jcite">2010 BL 149061</a>], 2010 U.S. Dist. LEXIS 67109, at *34 (allowing plaintiff's negligent
manufacturing claims to proceed under Texas law). Therefore, we hold that
the district court erred in dismissing Bass's negligent manufacturing
claims.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>3. Express Warranty</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We agree with <i>Medtronic</i> that the express warrantyclaims cannot be used to
impose requirements greater than that provided by the FDA regulations.

<i>Medtronic</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EBQAK003?jcsearch=623%20f%203d%201200&amp;summary=yes#jcite">623 F.3d at 1207</a>. To the extent that Bass is claiming that
Stryker made some affirmative representation of compliance with FDA
manufacturing processes, he has done so only in a wholly conclusory <span CLASS="page_no" data-cite="2012 bl 31814 p 12" data-cite-type="Bloomberg" data-cite-pageno="12" data-primary-citation="">[*12]</span> fashion.
Therefore, we affirm the dismissal of Bass's express warranty claim. <i>See,</i>
<i>e.g.</i>, <i>Purcel</i>, [<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1Q6LCBBMLO2?jcsearch=2010%20BL%20149061&amp;summary=yes#jcite">2010 BL 149061</a>], 2010 U.S. Dist. LEXIS 67109, at *37; <i>Delaney</i>,
[<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1AM4Q2003?jcsearch=2009%20BL%2043259&amp;summary=yes#jcite">2009 BL 43259</a>], 2009 U.S. Dist. LEXIS 16865, at *16.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>4. Implied Warranties</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  To prevail on a breach of the implied warranty of merchantability, a
plaintiff must prove that: (1) "the defendant sold or leased the product to
the plaintiff; (2) the product was unmerchantable; (3) the plaintiff
notified the defendant of the breach; and (4) the plaintiff suffered
injury." <i>Purcel</i>, [<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1Q6LCBBMLO2?jcsearch=2010%20BL%20149061&amp;summary=yes#jcite">2010 BL 149061</a>], 2010 U.S. Dist. LEXIS 67109, at *23; <i>see also</i> Tex. Bus. &amp;
Com. Code Ann. &sect; <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X7ULFI003?jcsearch=Tex.%20Bus.%20%26%20Com.%20Code%20Ann.%20%202.314&amp;summary=yes#jcite">2.314</a> (West 2009). A product is unmerchantable if it is
"unfit for its ordinary purpose." <i>Purcel</i>, [<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1Q6LCBBMLO2?jcsearch=2010%20BL%20149061&amp;summary=yes#jcite">2010 BL 149061</a>], 2010 U.S. Dist. LEXIS 37109, at
*23.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  "To establish a breach of the implied warranty of fitness for a particular
purpose, the plaintiff must establish that (1) the seller had reason to know
any particular purpose for which the goods were required at the time of
contracting and (2) the buyer was relying on the seller's skill or judgment
to select or furnish suitable goods." <i>Hartford v. Lyndon-DFS Warranty</i>
<i>Servs.</i>, <i>Inc.</i>, No. <cite>01-08-00398-CV</cite>, [<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1DC7A0003?jcsearch=2010%20BL%20126669&amp;summary=yes#jcite">2010 BL 126669</a>], 2010 Tex. App. LEXIS 4241, at *28-29 (Tex.
App.-Houston [1st Dist.] May 28, 2010, no pet.); <i>see also</i>
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X7ULFK003?jcsearch=Tex.Bus.%26Com.Code%20Ann.%202.315&amp;summary=yes#jcite">Tex.Bus.&amp;Com.CodeAnn.&sect; 2.315</a> (West 2009).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Some courts that have considered this issue have concluded that implied
warranty claims are preempted because a finding that a product is
unmerchantable or unfit for the purpose for which it is intended conflicts
with the PMA process, through which the FDA has explicitly approved the
device. <i>See Michael v. Shiley</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X39HNU?jcsearch=46%20f%203d%201316&amp;summary=yes#jcite">46 F.3d 1316</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X39HNU?jcsearch=46%20f%203d%201316&amp;summary=yes#jcite">1325</a> (3d Cir. 1995); <i>King v.</i>
<i>Collagen Corp.</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X3ADRR?jcsearch=983%20f%202d%201130&amp;summary=yes#jcite">983 F.2d 1130</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X3ADRR?jcsearch=983%20f%202d%201130&amp;summary=yes#jcite">1135-36</a> (1st Cir. 1993). However, both
<i>Michael</i> and <i>King</i> were decided before the Supreme Court's decisions in <i>Lohr</i>
and <i>Riegel</i>. In <i>Riegel</i>, the

Supreme Court affirmed the dismissal of the plaintiff's negligence, strict
liability, and implied warranty claims, but noted that this was because the
district court "interpreted the claims [in that case] to assert that
Medtronic's device violated state tort law notwithstanding compliance with
the relevant federal requirements. . . ." <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20us%20312&amp;summary=yes#jcite">552 U.S. at 330</a>. The Court
explicitly stated that "<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5Q2003?jcsearch=21%20U.S.C.%20%20360k&amp;summary=yes#jcite">&sect; 360k</a> does not prevent a State from providing a
damages remedy for claims premised on a violation of FDA regulations; the
state duties in such a case `parallel,' rather than add to, federal
requirements." <i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20U.S.%20312&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Several courts that have addressed whether implied warranty claims are
preempted after <i>Riegel</i> have determined that, to the extent the plaintiff
relies on the failure to comply with the FDA's requirements in asserting its
breach of implied warranty claim, such claims may proceed. <i>E.g., Hofts v.</i>
<i>Howmedica Osteonics Corp.</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1AJB4O003?jcsearch=597%20f%20supp%202d%20830&amp;summary=yes#jcite">597 F. Supp. 2d 830</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1AJB4O003?jcsearch=597%20f%20supp%202d%20830&amp;summary=yes#jcite">839-40</a> (S.D. Ind. 2009)
(concluding that an implied warranty claim could proceed unless it "rested
on allegations about standards other than those permitted by the FDA . .
.")<a HREF="#fn300" name="fnref_fn300">[fn3]</a>; <i>Gelber v. Stryker Corp.</i>, No. <cite>09-Civ-1322</cite>,
[<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1FAERS003?jcsearch=788%20F.%20Supp.%202d%20145&amp;summary=yes#jcite">788 F. SUPP. 2D 145</a>], 2011 U.S. Dist. LEXIS 41758, at *22 (S.D.N.Y. Apr. 18, 2011) (concluding
that "Plaintiffs' implied warranty claims are not preempted to the extent
they allege a defective manufacturing claim . . ."); <i>Purcel</i>,
[<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1Q6LCBBMLO2?jcsearch=2010%20BL%20149061&amp;summary=yes#jcite">2010 BL 149061</a>], 2010 U.S. Dist. LEXIS 67109, at *38-39; <i>Kallal v. Ciba Vision Corp.</i>, No.
<cite>09-CV-3346,</cite> [<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1DDG1O003?jcsearch=2010%20BL%20129052&amp;summary=yes#jcite">2010 BL 129052</a>], 2010 U.S. Dist. LEXIS 56838, at *8 (N.D. Ill. June 9, 2010)
(concluding that the plaintiff's claims related to violation of a federal
standard could proceed). Most post-<i>Riegel</i> cases that have found implied
warranty claims preempted either concluded that

the claims failed to rely on violations of the FDA's requirements, or the
plaintiff pleaded that the defendants <span CLASS="page_no" data-cite="2012 bl 31814 p 13" data-cite-type="Bloomberg" data-cite-pageno="13" data-primary-citation="">[*13]</span> complied with the FDA's requirements.
<i>E.g.</i>, <i>Horn v. Boston Sci. Neuromodulation Corp.</i>, No. <cite>CV409-074</cite>,
[<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1G4R1I003?jcsearch=436%20Fed.%20Appx.%20496&amp;summary=yes#jcite">436 FED. APPX. 496</a>], 2011 U.S. Dist. LEXIS 102164, at *16-19 (S.D. Ga. Aug. 26, 2011) (dismissing
an implied warranty claim but stating that the claim wouldhave survived if
the plaintiff had properly pleaded a failure to comply with FDA
requirements); <i>Walker v. Medtronic, Inc.</i>, No. <cite>2:07-00317</cite>,
[<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EL55O003?jcsearch=2010%20BL%20278663&amp;summary=yes#jcite">2010 BL 278663</a>], 2010 U.S. Dist. LEXIS 125103, at *21 (S.D. W. Va. Nov. 24, 2010) (finding
that the implied warranty claim was preempted because there was no
allegation of non-compliance with FDA standards); <i>Yost v. Stryker Corp.</i>, No.
<cite>2:09-Cv-28-FtM-29DNF</cite>, [<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1CSNVU003?jcsearch=2010%20BL%2062527&amp;summary=yes#jcite">2010 BL 62527</a>], 2010 U.S. Dist. LEXIS 27079, at *12-13 (M.D. Fla. Mar.
23, 2010) (same). <i>But see In re Medtronic, Inc. Sprint Fidelis Leads Prods.</i>
<i>Liab. Litig.</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1Q6L3POU4O2?jcsearch=592%20f%20supp%202d%201147&amp;summary=yes#jcite">592 F. Supp. 2d 1147</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1Q6L3POU4O2?jcsearch=592%20f%20supp%202d%201147&amp;summary=yes#jcite">1163-64</a> (D. Minn. 2009) (concluding that
the plaintiff's implied warranty claim was preempted despite the plaintiff's
allegation that the device was not manufactured in accordance with CGMPs),
<i>aff'd</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EBQAK003?jcsearch=623%20f%203d%201200&amp;summary=yes#jcite">623 F.3d 1200</a> (8th Cir. 2010).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We agree with the courts that hold that an implied warranty claim is not
preempted if the plaintiff alleges that the defendant violated federal
requirements <i>and</i> can ultimately show a causal link between the violation and
the breach of the implied warranty. If, however, the plaintiff claims that
the defendant breached the implied warranty despite its compliance with FDA
requirements, that claim is clearly preempted, as it would be "'different
from, or in addition to,' the requirements imposed by federal law." <i>See</i>
<i>Riegel</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20us%20312&amp;summary=yes#jcite">552 U.S. at 330</a> (quoting <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5Q2003?jcsearch=21%20U.S.C.%20%20360k(a)(1)&amp;summary=yes#jcite">21 U.S.C. &sect; 360k</a>(a)(1)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Here, the issue is whether Bass sufficiently pleaded that his breach of
implied warranty claims are causally related to Stryker's alleged violations
of the FDA's requirements. Bass incorporated all of his factual allegations
into his claim that Stryker breached the implied warranties of
merchantability and fitness for a particular purpose, and he sets out that
Stryker manufactured the

Shell in violation of the FDA requirements and received the Warning Letter
from the FDA because the Shell was "adulterated." Therefore, although this
portion of the complaint is not a model of clarity, to the extent that he
bases his breach of implied warranty claims on violations of federal
requirements, those claims survive. To the extent he alleges that Stryker
complied with the FDA requirements, his implied warranty claims are
preempted.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>5. DTPA</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finally, Bass asserts a violation of the DTPA. Stryker's briefing before
the district court noted that the Texas Supreme Court found that DTPA claims
are preempted by the MDA in <i>Worthy.</i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XAJI00?jcsearch=967%20south%20western%202d%20360&amp;summary=yes#jcite">967 S.W.2d at 376-77</a>. <i>Worthy</i> is
distinguishable because the plaintiff in that case did not "contend that
[the drug] was manufactured, marketed, or injected in her in any way other
than that approved by the FDA." <i></i><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XAJI00?jcsearch=967%20S.W.2d%20360&amp;summary=yes#jcite">Id. at 376</a>. Here, of course, Bass does
allege that the Shell was manufactured in violation of FDA regulations.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  It appears that Bass alleges two theories of violation of the DTPA:
misrepresentation and breach of implied warranty. To the extent that Bass's
claim relies on a misrepresentation, it is essentially asserting a failure
to warn claim that is preempted for the reasons discussed above. To the
extent that Bass's DTPA claim relies upon a breach of implied warranty, we
allow it to go forward, subject to the limitations discussed in the implied
<span CLASS="page_no" data-cite="2012 bl 31814 p 14" data-cite-type="Bloomberg" data-cite-pageno="14" data-primary-citation="">[*14]</span> warranty section above.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>IV. CONCLUSION</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For the foregoing reasons, we AFFIRM the dismissal of Bass's strict
liability, negligence, and DTPA claims inasmuch as they are premised on a
failure to warn or a marketing defect; AFFIRM as to Bass's breach of express
warranty claims; and REVERSE and REMAND the following: (1) Bass's strict
liability claim, to the extent it is based on a manufacturing defect; (2)
his negligent manufacturing claim; (3) his claim for breach of an implied
warranty; and (4) his DTPA claim, to the extent that it relies on a breach
of an implied

warranty.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> Other courts have also concluded at the motion to dismiss stage that
the Shells were subject to the PMA process. See Lewkut v. Stryker Corp.,
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XIAMVON?jcsearch=724%20f%20supp%202d%20648&amp;summary=yes#jcite">724 F. Supp. 2d 648</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XIAMVON?jcsearch=724%20f%20supp%202d%20648&amp;summary=yes#jcite">657</a> (S.D. Tex. 2010) ("[T]hat the acetabular shell was
previously approved through only the <cite>&sect; 510(k)</cite> process . . . does not change
the fact that it was later subject to the more rigorous scrutiny of the PMA
process as a component of the Trident System."); see also Cornwell v.
Stryker Corp., No. <cite>1:10-cv-00066</cite>, [<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1EIFE2003?jcsearch=2010%20BL%20259272&amp;summary=yes#jcite">2010 BL 259272</a>], 2010 U.S. Dist. LEXIS 116824, at *8 (D.
Idaho Nov. 1, 2010); Phillips v. Stryker Corp., No. <cite>3:09-CV-488</cite>,
[<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1DBQ24003?jcsearch=2010%20BL%20123179&amp;summary=yes#jcite">2010 BL 123179</a>], 2010 U.S. Dist. LEXIS 55117, at *14-15 (E.D. Tenn. June 3, 2010); Delaney v.
Stryker Orthopaedics, No. <cite>08-03210</cite>, [<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1AM4Q2003?jcsearch=2009%20BL%2043259&amp;summary=yes#jcite">2009 BL 43259</a>], 2009 U.S. Dist. LEXIS 16865, at *10
(D.N.J. Mar. 5, 2009) ("[Plaintiff] further argues that discovery is needed
to determine if all or only part of the Trident TM was subject to the PMA
process. Discovery is not required in this instance because [Stryker] has
sufficiently demonstrated that the Trident TM underwent the PMA process.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn200" name="fn200">[fn2]</a></span> Although neither party discusses this in its brief, parts of the
district court's order dismissing the suit appear to be premised upon Bass's
original complaint rather than the amended complaint. To the extent that the
district court relied on the original complaint, such reliance was error.
The amendment was filed before Stryker filed a responsive motion, and
therefore no leave of the district court was required. <i>See</i> Fed. R. Civ. P.
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X144L1C003?jcsearch=Fed.%20R.%20Civ.%20P.%2015&amp;summary=yes#jcite">15</a>; <i>see also Santee v. Quinlan</i>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XAC9D9?jcsearch=115%20f%203d%20355&amp;summary=yes#jcite">115 F.3d 355</a>, <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XAC9D9?jcsearch=115%20f%203d%20355&amp;summary=yes#jcite">357</a> (5th Cir. 1997). Because
the complaint was amended as of right, our analysis proceeds as to the
Amended Complaint.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn300" name="fn300">[fn3]</a></span> The court in <i>Hofts</i> relied in part on <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XMJ99E003?jcsearch=21%20C.F.R.%20%20808.1(d)(1)&amp;summary=yes#jcite">21 C.F.R. &sect; 808.1</a>(d)(1), to
conclude that the implied warranty claims were not preempted.
<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1AJB4O003?jcsearch=597%20f%20supp%202d%20830&amp;summary=yes#jcite">597 F. Supp. 2d at 839</a>. <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XMJ99E003?jcsearch=21%20C.F.R.%20%20808.1(d)(1)&amp;summary=yes#jcite">Section 808.1(d)</a>(1) states that "<a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5Q2003?jcsearch=21%20U.S.C.%20%20360k&amp;summary=yes#jcite">Section 521(a)</a> [of
the FDCA, or <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XEI5Q2003?jcsearch=21%20usc%20360k&amp;summary=yes#jcite">21 U.S.C. &sect; 360k</a>] does not preempt State or local requirements
of general applicability where the purpose of the requirement relates either
to other products in addition to devices (e.g., requirements such as general
electrical codes, and the Uniform Commercial Code (warranty of fitness)), or
to unfair trade practices in which the requirements are not limited to
devices." <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/XMJ99E003?jcsearch=21%20C.F.R.%20%20808.1(d)(1)&amp;summary=yes#jcite">21 C.F.R. &sect; 808.1</a>(d)(1). The Supreme Court rejected a similar
argument in <i>Riegel</i>. <a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X18HPKU003?jcsearch=552%20us%20312&amp;summary=yes#jcite">552 U.S. at 328-29</a>. We do not address this issue, as we
do not rely on this regulation in holding that Bass's implied warranty
claims may proceed.
</p></div>
</div>
<!--BBLS DD 1688055382019-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1H43V2003/history">Direct History (2)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1H43V2003/analysis">Case Analysis (41)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1H43V2003/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
41
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Judgment Affirmed (In Part), Judgment Reversed (In Part), Case Remanded</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Industries</div><div class='facetItemLabel'>Manufacturing</div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/document/X1Q6LGT9UHO2">11-10076 (5th Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Contracts</div><div class='facetItemLabel'>Products Liability</div><div class='facetItemLabel'>Torts</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/2d1c5bdac65af3818981b8f10bc7a699/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "2d1c5bdac65af3818981b8f10bc7a699";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY6ca2b2&previousPageId=&previousActivityInstanceId=ENTITY5a0dc9&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:32:40-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1H43V2003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY5a0dc9&previousPageId=&previousActivityInstanceId=ENTITY330c67&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:32:30-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1H43V2003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1H43V2003";
$('#page_loader').show().spin();
JUDGE_IDS=["17141920","3028300"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
